WHO expands contraceptive options, endorses longer‑lasting methods
WHO releases new guidelines that extend the use of existing contraceptives and add mifepristone as an emergency option
In Brief
- •WHO releases new guidelines that extend the use of existing contraceptives and add mifepristone as an emergency option
- •Guidelines allow combined oral contraceptive pills to be taken continuously for up to one year and implants for up to five years
- •WHO estimates 164 million women who wish to delay or avoid pregnancy are not currently using contraception
- •Survey data shows over 75 % of couples would use a new male contraceptive and over 85 % of women trust partners to take responsibility
Why It Matters
The expanded guidance gives individuals more flexibility in choosing methods that fit their lifestyles, potentially increasing contraceptive uptake and reducing unintended pregnancies. By supporting longer‑lasting options and male‑directed methods, WHO aims to reduce clinic visits, lower costs, and promote gender equity in reproductive health decisions.
Key Details
- Women not using contraception
- 164 million
- Extended pill use
- up to 1 year
- Implant duration
- up to 5 years
- Mifepristone window
- within 5 days of unprotected sex
- Couples willing to use male contraceptive
- >75 %
Context & Background
WHO has historically issued family‑planning guidance; this update builds on earlier recommendations to broaden access and improve method choice worldwide.
Original Reporting & Sources
VNews is an independent briefing product. Original reporting remains credited to the following publishers:
This brief was synthesized automatically using attributed third-party reporting. VNews is a digital news publication produced under the VContent Group brand and operated by Francis Vincent Sunday in Ghana, independent from the publishers cited above. Read our AI Transparency Policy and Editorial & Corrections Policy.